Finger-prick test can diagnose ‘most common STI you’ve never heard of’ in just 5 minutes Researchers from Washington State University developed the 5-minute test Results of the at-home test are read in a similar way to a Covid or pregnancy test A new finger-prick test can diagnose one of the world’s…
Interplay between Western diet, gut microbiota, and cancer development
In a review article published in the journal Seminars in Immunology, scientists have explored the relationship between the Western diet, gut microbiota, and cancer development. Study: Western diet influences on microbiome and carcinogenesis. Image Credit: Keri Delaney / Shutterstock Background A complex interplay between several modifiable factors, including diet, lifestyle, and environment,…
Doctors Checklist for Treating Long COVID Patients
Editor’s note: Find the latest long COVID news and guidance in Medscape’s Long COVID Resource Center. Lisa McCorkell had a mild bout of COVID-19 in March 2020. Young and healthy, she assumed that she would bounce back quickly. But when her fatigue, shortness of breath, and brain fog persisted, she…
New study identifies approach for improving end-of-life conversations for people with cancer
Source: Read Full Article
In Afghanistan, poverty, lack of education associated with dementia
Poverty was closely associated with higher rates of dementia among older adults in Afghanistan, according to a newly published study in eClinicalMedicine by Jean-Francois Trani, an associate professor at the Brown School. The results suggest that addressing education, health, employment and living conditions earlier in life can have an impact…
Blood-based biomarkers for Alzheimer’s disease could make diagnostic workup more accurate, cost-effective
An international research team led by the HUG and the UNIGE has shown that amyloid and tau blood-based biomarkers are highly correlated with the corresponding biomarkers used so far for the diagnosis of Alzheimer's disease. Furthermore, the blood-based biomarkers showed high diagnostic accuracy in discriminating the normal or non-normal status…
Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO
Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients, today announced the close of its $28 million series A funding round. The Company also announces the appointment of former Novartis Oncology SVP Brian Gladsden as CEO. The…
Cesarean Deliveries Drop in Women at Low Risk
Cesarean deliveries in women in the United States who were at low risk for the procedure declined overall during the 2 decades from 2000 to 2019, based on data from more than 40 million deliveries. Although clinically indicated cesarean deliveries may improve outcomes for mothers and infants, “when not clinically…
Research provides new insights into the underlying disease mechanisms for polycystic kidney disease
Autosomal dominant polycystic kidney disease (ADPKD) is the most common potentially lethal genetic disease-;about a half million people in the United States alone suffer from the condition. There is no cure, but new research could open the door to new gene therapies for treating most cases of the disease. For…
N-abling the acceleration of the life sciences through precision dispensing
insights from industryHolger EickhoffFounder and CEOScienion In this interview, we speak to Holger Eickhoff, CEO and Founder of Scienion, about their latest technology, The Nucleus Automation Ecosystem, and how it will bring new flexibility to the manufacturing market in life sciences. Please can you introduce yourself and tell us about…